Aug 28, 2025

  • Corporate

Personnel Change

TOKYO, August 28, 2025 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel change, effective September 1, 2025.

[Details of Personnel Change]
Executive Officer

NameNew ResponsibilitiesCurrent Responsibilities
Kaori Ouchi

Executive Vice President
Supervisory responsibility for Risk Management, Compliance and Quality & Regulatory Compliance, Pharmaceutical Technology, Manufacturing Technology
In charge of Risk & Compliance Dept.
Head of Risk & Compliance Dept.

Executive Vice President
Supervisory responsibility for Risk Management, Compliance and Quality & Regulatory Compliance, Pharmaceutical Technology, Manufacturing Technology
In charge of Risk & Compliance Dept.

[PDF 127KB]

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Hideki Sato
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Takayuki Sakurai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp

Back